Your browser doesn't support javascript.
loading
CD82 controls CpG-dependent TLR9 signaling.
Khan, Nida S; Lukason, Daniel P; Feliu, Marianela; Ward, Rebecca A; Lord, Allison K; Reedy, Jennifer L; Ramirez-Ortiz, Zaida G; Tam, Jenny M; Kasperkovitz, Pia V; Negoro, Paige E; Vyas, Tammy D; Xu, Shuying; Brinkmann, Melanie M; Acharaya, Mridu; Artavanis-Tsakonas, Katerina; Frickel, Eva-Maria; Becker, Christine E; Dagher, Zeina; Kim, You-Me; Latz, Eicke; Ploegh, Hidde L; Mansour, Michael K; Miranti, Cindy K; Levitz, Stuart M; Vyas, Jatin M.
Afiliação
  • Khan NS; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Lukason DP; Biomedical Engineering and Biotechnology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Feliu M; Biomedical Engineering and Biotechnology, University of Massachusetts Lowell, Lowell, Massachusetts, USA.
  • Ward RA; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Lord AK; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Reedy JL; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Ramirez-Ortiz ZG; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Tam JM; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Kasperkovitz PV; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Negoro PE; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Vyas TD; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Xu S; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Brinkmann MM; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Acharaya M; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Artavanis-Tsakonas K; F. Hoffmann-La Roche Innovation Center Basel, Basel, Switzerland.
  • Frickel EM; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Becker CE; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Dagher Z; Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Kim YM; Viral Immune Modulation Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Latz E; Institute of Genetics, Technische Universität Braunschweig, Braunschweig, Germany.
  • Ploegh HL; Benaroya Research Institute, Seattle, Washington, USA.
  • Mansour MK; Center for Immunity and Immunotherapy, Seattle Children's Research Institute, Seattle, Washington, USA.
  • Miranti CK; Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Levitz SM; Host-Toxoplasma Interaction Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Vyas JM; Center for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
FASEB J ; 33(11): 12500-12514, 2019 11.
Article em En | MEDLINE | ID: mdl-31408613
ABSTRACT
The tetraspanin CD82 is a potent suppressor of tumor metastasis and regulates several processes including signal transduction, cell adhesion, motility, and aggregation. However, the mechanisms by which CD82 participates in innate immunity are unknown. We report that CD82 is a key regulator of TLR9 trafficking and signaling. TLR9 recognizes unmethylated cytosine-phosphate-guanine (CpG) motifs present in viral, bacterial, and fungal DNA. We demonstrate that TLR9 and CD82 associate in macrophages, which occurs in the endoplasmic reticulum (ER) and post-ER. Moreover, CD82 is essential for TLR9-dependent myddosome formation in response to CpG stimulation. Finally, CD82 modulates TLR9-dependent NF-κB nuclear translocation, which is critical for inflammatory cytokine production. To our knowledge, this is the first time a tetraspanin has been implicated as a key regulator of TLR signaling. Collectively, our study demonstrates that CD82 is a specific regulator of TLR9 signaling, which may be critical in cancer immunotherapy approaches and coordinating the innate immune response to pathogens.-Khan, N. S., Lukason, D. P., Feliu, M., Ward, R. A., Lord, A. K., Reedy, J. L., Ramirez-Ortiz, Z. G., Tam, J. M., Kasperkovitz, P. V., Negoro, P. E., Vyas, T. D., Xu, S., Brinkmann, M. M., Acharaya, M., Artavanis-Tsakonas, K., Frickel, E.-M., Becker, C. E., Dagher, Z., Kim, Y.-M., Latz, E., Ploegh, H. L., Mansour, M. K., Miranti, C. K., Levitz, S. M., Vyas, J. M. CD82 controls CpG-dependent TLR9 signaling.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligodesoxirribonucleotídeos / Transdução de Sinais / Núcleo Celular / Receptor Toll-Like 9 / Proteína Kangai-1 / Macrófagos Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligodesoxirribonucleotídeos / Transdução de Sinais / Núcleo Celular / Receptor Toll-Like 9 / Proteína Kangai-1 / Macrófagos Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article